Toggle Offcanvas
...
 
Pimecrolimus Tenders

Pimecrolimus Tenders

View Pimecrolimus tenders, RFPs and contracts. Bid on readily available Pimecrolimus tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Pimecrolimus tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Pimecrolimus.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Pimecrolimus market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Pimecrolimus tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

16 Live Notices for Pimecrolimus Tenders

Showing 1 to 16

Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
country Germany
posting date05 Dec 2024
deadline05 Dec 2026
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
country Germany
posting date26 Nov 2024
deadline05 Dec 2026
Open House Drug Discount Agreements Pimecrolimus, Atc D11Ah02
country Germany
posting date17 Jun 2024
deadline05 Jun 2026
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Pimecrolimus (D11Ah02) As Part Of A So-Called Open House Model.
country Germany
posting date21 Mar 2024
deadline28 Feb 2026
Open House Contracts For Multiple Active Ingredients/Active Ingredient Combinations
country Germany
posting date04 Jul 2023
deadline02 May 2025
Open House Contracts For Multiple Active Ingredients/Active Ingredient Combinations
country Germany
posting date16 May 2023
deadline02 May 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Substance Pimecrolimus, Atc D11Ah02 For The Period May 1St, 2023 - April 30Th, 2025
country Germany
posting date20 Mar 2023
deadline05 Mar 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Substance Pimecrolimus, Atc D11Ah02 For The Period May 1St, 2023 - April 30Th, 2025
country Germany
posting date18 Mar 2023
deadline05 Mar 2025
Pimecrolimus Creme Ba1.13.B
country Denmark
posting date27 Jan 2025
deadline01 Apr 2025
Pimecrolimus Creme Ba1.13.B
country Denmark
posting date27 Dec 2024
deadline01 Apr 2025
Pimecrolimus Creme Ba1.13.B
country Denmark
posting date26 Nov 2024
deadline01 Apr 2025
Pimecrolimus Creme Ba1.13.B
country Denmark
posting date28 Oct 2024
deadline01 Apr 2025
Pimecrolimus Creme Ba1.13.B
country Denmark
posting date26 Sep 2024
deadline01 Apr 2025
Pimecrolimus Creme Ba1.13.B
country Denmark
posting date26 Aug 2024
deadline01 Apr 2025
Pimecrolimus Creme Ba1.13.B
country Denmark
posting date18 Jun 2024
deadline01 Apr 2025
Pimecrolimus Creme Ba1.13.B
country Denmark
posting date26 Jul 2024
deadline01 Apr 2025

Share Share this page